Cite
Nebbioso A, Manzo F, Miceli M, et al. Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes. EMBO Rep. 2020;21(12):e51028doi: 10.15252/embr.202051028.
Nebbioso, A., Manzo, F., Miceli, M., Conte, M., Manente, L., Baldi, A., De Luca, A., Rotili, D., Valente, S., Mai, A., Usiello, A., Gronemeyer, H., & Altucci, L. (2020). Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes. EMBO reports, 21(12), e51028. https://doi.org/10.15252/embr.202051028
Nebbioso, Angela, et al. "Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes." EMBO reports vol. 21,12 (2020): e51028. doi: https://doi.org/10.15252/embr.202051028
Nebbioso A, Manzo F, Miceli M, Conte M, Manente L, Baldi A, De Luca A, Rotili D, Valente S, Mai A, Usiello A, Gronemeyer H, Altucci L. Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes. EMBO Rep. 2020 Dec 03;21(12):e51028. doi: 10.15252/embr.202051028. Epub 2020 Nov 26. PMID: 33438796; PMCID: PMC7726812.
Copy
Download .nbib
